Funder: National Institutes of Health
Due Dates (Anticipated): January 2027 | January 2026
Funding Amounts: Award size varies by phase; typical Phase I and II STTR awards; duration and ceiling not specified in forecast.
Summary: Supports U.S. small businesses to develop and commercialize innovative health-related technologies through collaborative R&D requiring clinical trials.
Key Information: This is a forecasted opportunity; actual solicitation and details pending program reauthorization.